Back to all announcements

DJ DXS International plc Dxs International Plc : Agm Statement

   At today's AGM, David Immelman, CEO of DXS International plc, the 
developer and supplier of clinical decision support solutions to the NHS, 
will be making the following statement: 
   We are delighted to announce that after a two and a half year process 
DXS International is the first of the 13 companies, which were awarded 
approved supplier agreements with the NHS in 2014, to receive FRA ("full 
rollout approval"). This means that Groups of GPs can now purchase DXS 
via a centrally funded initiative. 
   We have previously indicated that our turnover for the year ending April 
2015 had increased by 50% over the previous year and I am pleased to 
report that for the five months to September 2015 this trend has 
continued and shows an increase of 42% compared to the same period last 
year. The current revenue run rate is GBP3.2 million p.a. 
   Again during the course of the last financial year, we recruited 
additional staff to ensure continued delivery of an excellent and 
compliant service to the NHS which includes enhancements to Support, 
Clinical Safety, Disaster Recovery, Deployment and Training. To achieve 
FRA, the Company underwent a comprehensive 8 month due diligence process 
which included reviews of the requisite systems for the above and passed 
with flying colours. 
   The Company is now well positioned to capitalise on the NHS contract and 
is focused on increasing its sales and marketing activities. 
   In line with our customer needs, we continue a program of evolving and 
improving our current products and services as well as developing new 
products and services, driven by customer and market needs. 
   We are confident for the future of DXS and look forward to reporting the 
results for the half year to 31 October 2015 in mid-December. 
   The Directors of DXS accept responsibility for this announcement 
David Immelman, CE0 
 DXS International plc                       01252 719800 
City & Merchant Ltd (Corporate Adviser) 
David Papworth                            0207 101 7676 
MB Communications (Financial PR) 
Maxine Barnes                              07860 489571 
   About DXS: 
   DXS International presents up to date treatment guidelines and 
recommendations, from Clinical Commissioning Groups and other trusted 
NHS sources, to doctors, nurses and pharmacists in their workflow and 
during the patient consultation. This effective clinical decision 
support ultimately translates to improved healthcare outcomes delivered 
more cost effectively which should significantly contribute towards the 
NHS achieving its projected efficiency savings. 
   This announcement is distributed by NASDAQ OMX Corporate Solutions on 
behalf of NASDAQ OMX Corporate Solutions clients. 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
   Source: DXS International plc via Globenewswire 

(END) Dow Jones Newswires

November 19, 2015 02:30 ET (07:30 GMT)